Literature DB >> 2047588

Endothelial cytotoxicity of Actinobacillus pleuropneumoniae.

S Serebrin1, S Rosendal, A Valdivieso-Garcia, P B Little.   

Abstract

The cytotoxicity of Actinobacillus pleuropneumoniae serotype 1 strain CM5 for porcine and bovine endothelial cells in vitro, was dose-dependent. This strain and its attenuated and avirulent substrain CM5A were equally cytotoxic. The cytotoxicity observed during five hours of exposure of endothelial cells to bacterial products was abolished if the bacteria were inactivated by heat or sonication. Exposure of the endothelial cells for five hours to 100 and 200 micrograms of purified lipopolysaccharide resulted in a partial cytotoxicity only, which was not enhanced in the presence of fresh guinea pig serum. The cytotoxicity of viable bacteria could be neutralised by a polyclonal rabbit antiserum to the purified 104kD haemolysin. A bacteria-free supernate of a culture of strain CM5 had both haemolytic and cytotoxic activity. The haemolytic activity could be neutralised completely by the anti-serum to the 104kD haemolysin, whereas the cytotoxic activity was only partially neutralisable. Hence A pleuropneumoniae is cytotoxic for endothelial cells and this cytotoxicity is possibly mediated by the 104kD haemolysin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2047588     DOI: 10.1016/0034-5288(91)90047-r

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  10 in total

1.  Association of the RTX proteins of Actinobacillus pleuropneumoniae with hemolytic, CAMP, and neutrophil-cytotoxic activities.

Authors:  J Devenish; J E Brown; S Rosendal
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Pathogenesis of porcine Actinobacillus pleuropneumonia: Part I. Effects of surface components of Actinobacillus pleuropneumoniae in vitro and in vivo.

Authors:  H Huang; A A Potter; M Campos; F A Leighton; P J Willson; W D Yates
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

3.  Influence of Actinobacillus pleuropneumoniae and its metabolites on porcine alveolar epithelial cells.

Authors:  A van de Kerkhof; F Haesebrouck; K Chiers; R Ducatelle; E M Kamp; M A Smits
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

4.  Activation of Porcine Alveolar Macrophages by Actinobacillus pleuropneumoniae Lipopolysaccharide via the Toll-Like Receptor 4/NF-κB-Mediated Pathway.

Authors:  Bi Li; Jing Fang; Zhicai Zuo; Sirui Yin; Tingting He; Mingxian Yang; Junliang Deng; Liuhong Shen; Xiaoping Ma; Shumin Yu; Ya Wang; Zhihua Ren
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 5.  Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host.

Authors:  Koen Chiers; Tine De Waele; Frank Pasmans; Richard Ducatelle; Freddy Haesebrouck
Journal:  Vet Res       Date:  2010-06-15       Impact factor: 3.683

6.  Actinobacillus pleuropneumoniae culture supernatants interfere with killing of Pasteurella multocida by swine pulmonary alveolar macrophages.

Authors:  W B Chung; L Bäckström; J McDonald; M T Collins
Journal:  Can J Vet Res       Date:  1993-07       Impact factor: 1.310

7.  Influence of Actinobacillus pleuropneumoniae serotype 2 and its cytolysins on porcine neutrophil chemiluminescence.

Authors:  P Dom; F Haesebrouck; E M Kamp; M A Smits
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  In vivo association of Actinobacillus pleuropneumoniae serotype 2 with the respiratory epithelium of pigs.

Authors:  P Dom; F Haesebrouck; R Ducatelle; G Charlier
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

Review 9.  Kingella kingae RtxA Cytotoxin in the Context of Other RTX Toxins.

Authors:  Katerina Filipi; Waheed Ur Rahman; Adriana Osickova; Radim Osicka
Journal:  Microorganisms       Date:  2022-02-27

10.  Actinobacillus pleuropneumoniae Interaction With Swine Endothelial Cells.

Authors:  Berenice Plasencia-Muñoz; Francisco J Avelar-González; Mireya De la Garza; Mario Jacques; Adriana Moreno-Flores; Alma L Guerrero-Barrera
Journal:  Front Vet Sci       Date:  2020-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.